Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06655129 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder

Study acronym: Anthelia
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 23, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The first IPL device obtained United States Food and Drug Administration (FDA) clearance in 1995 for treatment of lower extremity telangiectasias. Since then, its favorable cost and versatility in contrast to many singlespectrum lasers, has led to its rapid proliferation and use in a number of different clinical settings. As described in the literature, ANTHÉLIA medical device is intended to treat skin disorders: * Excessive Hairiness (Hirsutism, Hypertrichosis...) * Vascular lesions (Rosacea….) * Pigmented lesions (Lentigo et melasma) * Acne vulgaris
Trial Details
NCT Number NCT06655129
Lead Sponsor Eurofeedback
Conditions
(from sponsor)		 Excessive Hairiness, Vascular Lesion, Pigmented Lesions, Acne Vulgaris
Related terms Acne Vulgaris, Hirsutism
Enrollment 85 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov